Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities—A Case Report
Kralj et al., Critical Case Reports, doi:10.1002/ccr3.4010
Kralj et al., Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities—A Case Report, Critical Case Reports, doi:10.1002/ccr3.4010
Mar 2021   Source   PDF  
  All Studies   Meta
Case report of a high-risk immunocompromised patient with multiple comorbidities that had a mild case of COVID-19. The patient had UVB phototherapy three months earlier and had normal vitamin D levels (92.2 nmol/L, normal range 50-125).
Kralj et al., 5 Mar 2021, peer-reviewed, 2 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Vitamin D and COVID‐19 in an immunocompromised patient with multiple comorbidities—A Case Report
Martina Kralj, Hrvoje Jakovac
Clinical Case Reports, doi:10.1002/ccr3.4010
Routine 25-OH-Vitamin D3 measurement in COVID-19 patients could be of great importance, either for clinical course estimation or deciding on supplementation.
CONFLICT OF INTEREST None declared. AUTHOR CONTRIBUTIONS Martina Kralj managed the patient, collected the data, and contributed to the manuscript drafting. Hrvoje Jakovac interpreted the findings, reviewed the literature, drafted, and wrote the manuscript. Both authors have read and approved the final manuscript. ETHICAL CONSIDERATIONS The patient was informed in detail and he provided written consent.
Abu-Farha, Al-Mulla, Thanaraj, Impact of diabetes in patients diagnosed with COVID-19, Front Immunol
Ahlström, Frithiof, Hultström, The Swedish covid-19 intensive care cohort: risk factors of icu admission and icu mortality, Acta Anaesthesiol Scand
Ahmed, A Network-based analysis reveals the mechanism underlying vitamin D in suppressing cytokine storm and virus in SARS-CoV-2 infection, Front Immunol
Apicella, Campopiano, Mantuano, COVID-19 in people with diabetes: understanding the reasons for worse outcomes, Lancet Diabetes Endocrinol
Aygun, Vitamin D can prevent COVID-19 infection-induced multiple organ damage, Naunyn Schmiedebergs Arch Pharmacol
Balak, Gerdes, Parodi, Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature, Dermatol Ther (Heidelb)
Bernar, Kropshofer, Crazzolara, SARS-CoV-2 infection in a 7-year-old girl with pancytopenia during acute lymphocytic leukemia maintenance therapy, Pediatr Blood Cancer
Bulut, Kilic, Domínguez-Andrés, Overcoming immune dysfunction in the elderly: trained immunity as a novel approach, Int Immunol
Cantorna, Snyder, Lin, Vitamin D and 1,25(OH)2D regulation of T cells, Nutrients
Carleton, Cornetet, Huybers, Global evidence for ultraviolet radiation decreasing COVID-19 growth rates, Proc Natl Acad Sci U S A
Cashman, Dowling, Škrabáková, Vitamin D deficiency in Europe: pandemic?, Am J Clin Nutr
Castillo, Costa, Barrios, Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Steroid Biochem Mol Biol
Chiricozzi, Gisondi, Bellinato, Immune response to vaccination in patients with psoriasis treated with systemic therapies, Vaccines
Gauzzi, Fantuzzi, Reply to Jakovac: COVID-19, vitamin D, and type I interferon, Am J Physiol Endocrinol Metab
Ghazawi, Lim, Dutz, Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration, Int J Dermatol
Grant, Lahore, Mcdonnell, Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths, Nutrients
Grasselli, Greco, Zanella, risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy, JAMA Intern Med
Haustein, Rytter, Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment, J Eur Acad Dermatol Venereol
Holick, The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention, Rev Endocr Metab Disord
Hsu, Gordon, Silverberg, Serious infections in hospitalized patients with psoriasis in the United States, J Am Acad Dermatol
Jain, Chaurasia, Sengar, Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers, Sci Rep
Jakovac, COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?, Am J Physiol Heart Circ Physiol
Jakovac, COVID-19 and vitamin D-Is there a link and an opportunity for intervention?, Am J Physiol Endocrinol Metab
Jose, Bendickova, Kepak, Chronic inflammation in immune aging: role of pattern recognition receptor crosstalk with the telomere complex?, Front Immunol
Katz, Yue, Xue, Increased risk for COVID-19 in patients with vitamin D deficiency, Nutrition
Kim, Lee, Yang, Immunopathogenesis and treatment of cytokine storm in COVID-19, Theranostics
Krishnan, Hamilton, Alqahtani, Woreta, A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations, Intern Emerg Med
Kumar, Rathi, Haq, Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19, Virus Res
Lanini, Montaldo, Nicastri, COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study, PLoS One
Ling, Broad, Murphy, High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study, Nutrients
Liu, Baylin, Levy, Vitamin D deficiency and insufficiency among US adults: prevalence, predictors and clinical implications, Br J Nutr
Luo, Liao, Shen, Vitamin D deficiency is inversely associated with COVID-19 incidence and disease severity in Chinese People, J Nutr
Maghbooli, Sahraian, Ebrahimi, Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection, PLoS One
Mariani, Giménez, Bergam, Association between vitamin D deficiency and COVID-19 incidence, complications, and mortality in 46 countries: an ecological study
Mehta, Mcauley, Brown, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet
Mohammad, Aziz, Mahri, Obesity and COVID-19: what makes obese host so vulnerable?, Immun Ageing
Ohaegbulam, Swalih, Patel, Vitamin D supplementation in COVID-19 patients: a clinical case series, Am J Ther
Park, Lee, Bitoun, Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis, Ann Rheum Dis
Pasrija, Naime, The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease, Int Immunopharmacol
Pellegrini, Uzé, An old cytokine against a new virus?, J Interferon Cytokine Res
Pereira, Damascena, Azevedo, Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis, Crit Rev Food Sci Nutr
Qin, Bai, Liu, Clinical course and risk factors of disease deterioration in critically ill patients with COVID-19, Hum Gene Ther
Rehman, Fariha, Anwar, Novel coronavirus disease (COVID-19) pandemic: a recent mini review, Comput Struct Biotechnol J
Romagnoli, Peris, Gaudio, SARS-CoV-2 and COVID-19: From the Bench to the Bedside, Physiol Rev
Roth, Abrams, Aloia, Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low-and middle-income countries, Ann N Y Acad Sci
Sadeghinia, Daneshpazhooh, Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review, Dermatol Ther
Schend, Daniels, Sanan, Clinical observation of COVID-19 in a patient with an acquired humoral deficiency secondary to chemotherapeutic agents, Allergy Rhinol
Sharma, Li, Krishnan, Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases, Clin Sci (Lond)
Singhania, Bansal, Nimmatoori, Current overview on hypercoagulability in COVID-19, Am J Cardiovasc Drugs
Singhania, Bansal, Singhania, An atypical presentation of Novel Coronavirus Disease 2019 (COVID-19), Am J Med
Snfmi, Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients, Ann Rheum Dis
Sonani, Aslam, Goyal, COVID-19 vaccination in immunocompromised patients, Clin Rheumatol
Takeshita, Shin, Ogdie, Risk of serious infection, opportunistic infection, and herpes zoster among patients with psoriasis in the United Kingdom, J Invest Dermatol
Tan, Ho, Kalimuddin, Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19), Nutrition
Taneri, Gómez-Ochoa, Llanaj, a systematic review and meta-analysis
Teymoori-Rad, Shokri, Salimi, The interplay between vitamin D and viral infections, Rev Med Virol
Trend, Jones, Cha, Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome, Sci Rep
Wakkee, De Vries, Van Den Haak, Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort, J Am Acad Dermatol
Yang, Yu, Xu, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med
Yiu, Parisi, Lunt, Risk of hospitalisation and death due to infection in people with psoriasis: a population-based cohort study using the clinical practice research datalink, Br J Dermatol
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop